PATIENTS CHOICE LABORATORIES ACQUIRES MADISON AVENUE MEDICAL LABORATORY
Indianapolis, IN, July 21, 2016 (Newswire.com) - Patients Choice Laboratories, a privately held company, announced it has acquired Madison Avenue Medical Laboratory. The acquisition strengthens Patients Choice Laboratories’ ability to serve patients and providers in Central Indiana and the Midwest.
The acquisition fits into Patients Choice Laboratories’ strategy to operate as a full service laboratory, as well as enhance its global research capabilities in the areas of pharmacogenetics and women’s health.
“The acquisition of Madison Avenue Medical Laboratory expands our footprint throughout Central Indiana. We can now perform full service laboratory testing for patients, providers, employers and government entities statewide,” said Brad Moss, President of Patients Choice Laboratories. “The purchase also allows us to augment our research capabilities in the areas of women’s health, gene-based and molecular testing.”
Former owner of Madison Avenue Medical Laboratory, Larry Miller said, “We are excited to join Patients Choice Laboratories because of its innovative and cutting edge diagnostics solutions. We can now offer personalized medicine to the patients that we have served for many years.”
About Patients Choice Laboratories
Patients Choice Laboratories, based in Indianapolis, Indiana, is a leading provider of comprehensive laboratory testing services throughout the Midwest and Eastern United States. Since 2013, Patients Choice Laboratories has served patients and providers with a focus on providing fast, accurate and reliable results.
With three locations and full service laboratory testing services – Medication Monitoring, Women’s Health, Wellness and Pharmacogenetics – Patients Choice Laboratories offers an unmatched combination of innovative technologies, diagnostics options, convenience and comprehensive support. For more information, please visit www.pclabsindiana.com.
Contact:
Brad Moss
(317) 299-5227
bmoss@pclabsindiana.com
Source: Patients Choice Laboratories
